UniDoc Provides Update on Marketing Engagement
Further to the Company's news release of April 3, 2025, the Company believes that its renewed engagement of Rumble is in compliance with Policy 7.2 of the Canadian Securities Exchange (the "CSE") as the Company believes that the renewed engagement of Rumble is consistent with its financial resources and level of operations for the reasons outlined herein.
Since its engagement with Rumble started in April 2024, the Company has expended approximately $3.84 million on Rumble's investor relations marketing services. Rumble's services have primarily consisted of the creation of digital landing pages highlighting information about the Company and undertaking digital marketing campaigns to increase potential investor awareness of the Company. The Company's rationale for incurring these marketing expenditures is to maximize its ability to convert outstanding warrants into cash. The Company was successful in this initiative and was able to convert the majority (over 90%) of the outstanding warrants resulting in gross proceeds of approximately $8.8 million.
While the Company has begun commercial sales, and expects to increase its marketing budget for product awareness in the coming periods, the Company is not yet cashflow positive and cannot sustain operations from revenue alone. Since inception, it has relied on raising funds through the issuance of equity and exercise of in-the-money warrants, and will need to continue to do so going forward. The Company has raised a total of approximately $3.7 million from private placements and a further $9.7 million from the exercise of convertible securities since incorporation in 2021. The Company's ability to continue to raise capital through private placements and convertible securities depends in large part on maintaining liquidity in its stock, which is greatly assisted through undertaking investor awareness campaigns. The majority of the ~8.8 million in funds raised by the Company since Rumble's engagement in April 2024 have gone into, or have been allocated towards, the Company's general and administrative (including office & admin, consulting fees, professional fees and travel & entertainment) (~$1.4 million) and investor relations services (~$3.4 million). While the CEO's and other team members' salaries and travel expenses are not reflected in the financial statements as product marketing, a significant portion is attributable to those activities.
Further, the Company is pleased with its transition from development to sales and is extremely pleased that it expects to report its first revenue in fiscal Q4, which validates the efficacy of its product and buy-in from consumers. To date, the Company has received purchase orders from four separate arm's length end customers for an aggregate of 16 H3 Health Cube booths (two of such purchase orders came through a related party reseller, UniCheck S.r.l.), and has completed delivery of three of these booths. The Company expects to record revenue in Q4 related to two of these booths delivered to its reseller, UniCheck S.r.l. The Company donated the third booth to the end customer, and therefore does not expect to record corresponding revenue.
In light of its increase in operations, commencement of commercial sales, and successful financing activities, the Company believes that its investor relations marketing expenditures are both necessary and proportionate with both its level of operations and financial resources. That notwithstanding, given the natural long sales cycle for procuring and executing on sales in multiple health jurisdictions, there is a lag effect between marketing timing and sales timing that is currently normalizing as purchase are being fulfilled. Management expects investor relations marketing expenditures to significantly decrease and operational expenditures to significantly increase over the coming quarters.
On Behalf of the Board of Directors,
~Antonio Baldassarre~
Antonio Baldassarre CEO, President & Director UniDoc Health Corp.About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF)UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician's office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company's belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.comand signup to receive the latest information with updates on our activities, events and progress.
For further information, please contact:
UniDoc Investor Relations Tel: +1 778.383.6731Email: info@unidoctor.comMatt Chatterton, Director Tel: +1 778.613.2082Email: matt@unidoctor.com
Media Inquiries media@unidoctor.com
Forward-Looking StatementsThis news release contains statements and information that, to the extent that they are not historical fact, may constitute "forward-looking information" within the meaning of applicable securities legislation. Forward- looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as "may", "would", "could", "will", "will be", "likely", "except", "anticipate", "believe", "intend", "plan", "forecast", "project", "estimate", "outlook", or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the anticipated effectiveness of Rumble's investor awareness campaigns, the value of such services to the Company, the Company's anticipated future marketing and operational expenditures, and the sales cycles of the Company's products.
Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company's ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all; as well as all of the other risks as described in the Company's annual management discussion and analysis dated September 30, 2024 under the heading "Risks Factors." Accordingly, readers should not place undue reliance on any such forward-looking information.
Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company's management to predict all such factors and to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward- looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.The CSE does not accept responsibility for the adequacy or accuracy of this release.
SOURCE: UniDoc Health Corp.
View the original press release on ACCESS Newswire
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
UnitedHealth confirms federal investigation into its Medicare practices
UnitedHealth Group confirmed Thursday that its Medicare program is under investigation by the US Department of Justice and that it is working with the agency. The health insurer, which has been in upheaval since the murder of one of its top executives late last year, said in a statement it reached out to the Justice Department after media reports about the investigations. 'The Company has now begun complying with formal criminal and civil requests from the Department,' it said. 'The Company has full confidence in its practices and is committed to working cooperatively with the Department throughout this process.' The Justice Department is investigating UnitedHealth for potential criminal fraud in its Medicare Advantage program, the Wall Street Journal reported in May. The company is one of a number of insurers that the federal government contracts with to provide Medicare coverage to senior citizens and other enrollees. UnitedHealth reiterated on Thursday that it has launched third-party reviews of various policies and practices, including the codes it uses to evaluate patients' health status, its managed care practices and its pharmacy services. The investigation is the latest crisis for the nation's top insurer, which is also one of America's biggest corporations. The CEO of its health insurance unit, Brian Thompson, was gunned down on a New York City sidewalk in December, which unleashed a torrent of angry social media posts about care denials by UnitedHealth and other insurers. Andrew Witty, its former CEO, stepped down abruptly in May, shortly after the company suspended its financial outlook for the year, citing continued higher-than-expected costs in its Medicare Advantage program. UnitedHealth's former longtime CEO, Stephen Hemsley, has returned to lead the company. UnitedHealth's (UNH) stock has lost about half its value over the past year – more than $277 billion. It was down about 3.6% in late morning trading Thursday. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
43 minutes ago
- Business Wire
Offerpad Solutions Inc. Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement
TEMPE, Ariz.--(BUSINESS WIRE)--Offerpad Solutions Inc. ("Offerpad") (NYSE: OPAD), a leading tech-enabled platform for residential real estate, today announced that it has entered into a securities purchase agreement with a single institutional investor for the purchase and sale of 2,857,143 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering at a purchase price of $2.10 per share ('the Registered Offering'). The closing of the Offerings are expected to occur on or about July 25, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the Offerings are expected to be approximately $6 million. Share In a concurrent private placement (the "Private Placement" and together with the Registered Offering, the "Offerings"), the Company also agreed to issue to the same investor warrants to purchase up to 1,428,571 shares of its common stock (the "Common Warrants"). The Common Warrants have an exercise price of $2.30 per share, will be exercisable commencing six months from the date of issuance, and will expire four years following the initial exercise date. The closing of the Offerings are expected to occur on or about July 25, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the Offerings are expected to be approximately $6 million, before deducting placement agent fees and other estimated offering expenses. The Company expects to use the net proceeds from the Offerings for general working capital. A.G.P./Alliance Global Partners is acting as the sole placement agent for the Offerings. The Registered Offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-270994) previously filed with the U.S. Securities and Exchange Commission (the 'SEC'). A prospectus supplement describing the terms of the proposed Offering will be filed with the SEC and will be available on the SEC's website located at Electronic copies of the prospectus supplement may be obtained, when available, from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at prospectus@ The private placement of the Common Warrants and the shares underlying the Common Warrants offered to the institutional investor will be made in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"). Accordingly, the securities issued in the concurrent private placements may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. About Offerpad Offerpad, dedicated to simplifying the process of buying and selling homes, is a publicly traded company committed to providing comprehensive solutions that remove the friction from real estate. Our advanced real estate platform offers a range of services, from consumer cash offers to B2B renovation solutions and industry partnership programs, all tailored to meet the unique needs of our clients. Since 2015, we've leveraged local expertise in residential real estate alongside proprietary technology to guide homeowners at every step. #OPAD_IR Forward-Looking Statements This release contains 'forward-looking statements' made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are typically preceded by words such as 'believes,' 'expects,' 'anticipates,' 'intends,' 'will,' 'may,' 'should,' or similar expressions. These forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct or that those goals will be achieved, and you should be aware that actual results could differ materially from those contained in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, risks associated with market conditions and the satisfaction of customary closing conditions related to the proposed offering and uncertainties related to the size, timing, completion, and use of proceeds from the proposed offering. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the Company's business in general, please refer to the Company's prospectus supplement to be filed with the SEC, and the documents incorporated by reference therein, including the Company's Form 10-K for the year ended December 31, 2024 and Form 10-Q for the quarter ended March 31, 2025. All forward-looking statements are expressly qualified in their entirety by this cautionary notice. You are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this release. The Company has no obligation, and expressly disclaims any obligation, to update, revise or correct any of the forward-looking statements, whether as a result of new information, future events or otherwise.
CNN
an hour ago
- CNN
UnitedHealth confirms federal investigation into its Medicare practices
Health care policy Medicare Federal agenciesFacebookTweetLink Follow UnitedHealth Group confirmed Thursday that its Medicare program is under investigation by the US Department of Justice and that it is working with the agency. The health insurer, which has been in upheaval since the murder of one of its top executives late last year, said in a statement it reached out to the Justice Department after media reports about the investigations. 'The Company has now begun complying with formal criminal and civil requests from the Department,' it said. 'The Company has full confidence in its practices and is committed to working cooperatively with the Department throughout this process.' The Justice Department is investigating UnitedHealth for potential criminal fraud in its Medicare Advantage program, the Wall Street Journal reported in May. The company is one of a number of insurers that the federal government contracts with to provide Medicare coverage to senior citizens and other enrollees. UnitedHealth reiterated on Thursday that it has launched third-party reviews of various policies and practices, including the codes it uses to evaluate patients' health status, its managed care practices and its pharmacy services. The investigation is the latest crisis for the nation's top insurer, which is also one of America's biggest corporations. The CEO of its health insurance unit, Brian Thompson, was gunned down on a New York City sidewalk in December, which unleashed a torrent of angry social media posts about care denials by UnitedHealth and other insurers. Andrew Witty, its former CEO, stepped down abruptly in May, shortly after the company suspended its financial outlook for the year, citing continued higher-than-expected costs in its Medicare Advantage program. UnitedHealth's former longtime CEO, Stephen Hemsley, has returned to lead the company. UnitedHealth's (UNH) stock has lost about half its value over the past year – more than $277 billion. It was down about 3.6% in late morning trading Thursday.
